1 / 24

Development of a multivalent vaccine against Respiratory Syncytial Virus

Development of a multivalent vaccine against Respiratory Syncytial Virus. By Lucious Vaughn Alabama State University Department of Biological Sciences. Introduction.

Download Presentation

Development of a multivalent vaccine against Respiratory Syncytial Virus

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Development of a multivalent vaccine against Respiratory Syncytial Virus By Lucious Vaughn Alabama State University Department of Biological Sciences

  2. Introduction Human Respiratory Syncytial Virus (RSV) is the most common cause of bronchiolitis and pneumonia among infants and children, with almost everyone having contracted RSV at least once by the age of 2.

  3. The science of RSV • Family: Paramyxoviridae Genus: Pneumovirus • Negative sense single strand RNA virus translated into 11 proteins

  4. The Goal To design a multivalent vaccine against Respiratory Syncytial Virus • Multivalent- having several sites of attachment for an antibody or antigen. In this case F, M2, & G proteins.

  5. The Virus

  6. Genomics of RSV

  7. The F (fusion) protein • Viral penetration • Syncytium formation • High titers of neutralizing antibodies Syncytia

  8. The G (attachment) protein • Aides in the attachment of the virus to the host. • Has epitopes recognized by the host antibody response.

  9. The M2 (matrix) protein • M2-1:Transcription elongation factor • M2-2:Regulates viral transcription • Induces CD8 T-cells

  10. The F gene Entire length of F gene = omitted on purpose

  11. The M2 gene Entire length of M2 gene = omitted on purpose

  12. The G gene Entire length of G gene = omitted on purpose

  13. Newly designed multivalent gene FM2G Sal I- R.E. digestion end Nco I- R.E. digestion end

  14. pET-32a(+) Vector

  15. Linear view of pET-32a(+) Vector showing Restriction Enzyme sites Nco I Sal I

  16. Insertion and Cloning of multivalent gene with vector

  17. Test ligation 1 2 3 4 5 Lane-1: 1kb ladder Lane-2: RFM2G cut with Nco I Lane-3: pET-32 cut with Nco I and Sal I Lane-4: RFM2G cut with Nco I and Sal I Lane-5: 100kb ladder 550 bp Restriction enzyme analysis of multivalent gene on agarose gel

  18. The Methods CLONING PROTEIN EXPRESSION PROTEIN PURIFICATION IMMUNIZATION

  19. Expression of protein E. coli BL21 cells pET-32 with FM2G E. coli Protein expression

  20. SDS-PAGE analysis of multivalent protein 1 2 3 4 5 Lane-1: SDS-Marker Lane-2: Cytoplasmic Extract Lane-3: Soluble Fraction Lane-4: Pellet Lane-5: Purified FM2G protein 38KDa

  21. Western blot analysis of the multivalent protein 1 2 3 4 38KDa Lane-1: Pellet Lane-2: Soluble Fraction Lane-3: Cytoplasmic Extract Lane-4: Magic Marker 38KDa

  22. Conclusion • Multivalent gene cloned into pET-32a vector • Successful transformation • Successful protein expression • Confirmation analyses identified the created protein • Immunization testing in various specimens is presently ongoing

  23. REFERENCES • 1. Collins, P.L., et al., Nucleotide sequences for the gene junctions of human respiratory syncytial virus reveal distinctive features of intergenic structure and gene order. PNAS, 1986. 83: p. 4594-4598. • 2. Domachowske, J.B. and H.F. Rosenberg, Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin. Micro. Rev., 1999. 12(2): p. 298-309. • 3. Hacking, D. and J. Hull., Respiratory syncytial virus- Viral biology and the host response. Journal of infection., 2002. 45: p. 18-24.

More Related